Literature DB >> 25405832

Influence of recombinant lentiviral vector encoding miR-15a/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells.

Chunhong Zhang1, Xiaobi Fang, Wenfeng Li, Qingyuan Shi, Liping Wu, Xiaoyun Chen, Zhenxiao Huang, Peng Wu, Zhenzhen Wang, Zhisu Liao.   

Abstract

MicroRNAs can function as tumor suppressor miRNAs. Bcl-2 is an antiapoptotic gene overexpressed in many tumors, including nasopharyngeal carcinoma (NPC). It is reported that microRNA-15a (miR-15a) and microRNA-16-1 (miR-16-1) could act as bcl-2 inhibitors. To investigate their effects on NPC, the authors used recombinant lentiviral vector to upregulate the expression of miR-15a/16-1 in NPC CNE-2Z cells. The authors divided cells into the control group, transfection group, radiotherapy group, and transfection-radiotherapy group. In this experiment, reverse transcription-quantitative polymerase chain reaction was used to detect the expression of miR-15a/16-1 and bcl-2 mRNA. Cell proliferation was analyzed by MTT assay. Flow cytometry was used to measure cell apoptosis. Radiosensitivity was measured using colony-forming experiment. The protein expression of bcl-2 was measured by western blot, the activation levels of caspase were detected by a spectrophotometric method. After transfection, cell proliferation was inhibited, while the apoptosis rate and radiosensitivity were increased. In addition, the activation of caspase-2 and caspase-3 was aggrandized correspondingly. Although the expression levels of bcl-2 mRNA in each group had no difference, the protein expression of bcl-2 was downregulated. These results suggested that miR-15a/16-1 could inhibit cell proliferation and increase the apoptosis and radiosensitivity of CNE-2 cells, by regulating the bcl-2 gene at post-transcriptional level and by increasing the activation of caspase-2 and caspase-3.

Entities:  

Keywords:  apoptosis; bcl-2; microRNAs; nasopharyngeal carcinoma; radiosensitivity

Mesh:

Substances:

Year:  2014        PMID: 25405832     DOI: 10.1089/cbr.2013.1596

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  8 in total

1.  miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells.

Authors:  Vildan Bozok Çetintaş; Aslı Tetik Vardarlı; Zekeriya Düzgün; Burçin Tezcanlı Kaymaz; Eda Açıkgöz; Hüseyin Aktuğ; Buket Kosova Can; Cumhur Gündüz; Zuhal Eroğlu
Journal:  Tumour Biol       Date:  2015-08-28

2.  MiR-16-1 Targeted Silences Far Upstream Element Binding Protein 1 to Advance the Chemosensitivity to Adriamycin in Gastric Cancer.

Authors:  Danyi Zhao; Yang Zhang; Lei Song
Journal:  Pathol Oncol Res       Date:  2017-06-30       Impact factor: 3.201

3.  MiR-15a suppresses hepatocarcinoma cell migration and invasion by directly targeting cMyb.

Authors:  Bo Liu; Ting Sun; Gang Wu; Hui Shang-Guan; Zhao-Jin Jiang; Ji-Ren Zhang; Yan-Fang Zheng
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

4.  Polymorphisms in pre-miRNA genes and cooking oil fume exposure as well as their interaction on the risk of lung cancer in a Chinese nonsmoking female population.

Authors:  Zhihua Yin; Hang Li; Zhigang Cui; Yangwu Ren; Xuelian Li; Wei Wu; Peng Guan; Biyun Qian; Nathaniel Rothman; Qing Lan; Baosen Zhou
Journal:  Onco Targets Ther       Date:  2016-01-19       Impact factor: 4.147

5.  PPARβ/δ Agonist GW501516 Inhibits Tumorigenesis and Promotes Apoptosis of the Undifferentiated Nasopharyngeal Carcinoma C666-1 Cells by Regulating miR-206.

Authors:  Linglan Gu; Yi Shi; Weimin Xu; Yangyang Ji
Journal:  Oncol Res       Date:  2019-04-08       Impact factor: 5.574

6.  miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.

Authors:  Qingmei He; Xianyue Ren; Jiewei Chen; Yingqin Li; Xinran Tang; Xin Wen; Xiaojing Yang; Jian Zhang; Yaqin Wang; Jun Ma; Na Liu
Journal:  Oncotarget       Date:  2016-01-19

7.  Urinary miR-16 transactivated by C/EBPβ reduces kidney function after ischemia/reperfusion-induced injury.

Authors:  Hsi-Hsien Chen; Yi-Fan Lan; Hsiao-Fen Li; Ching-Feng Cheng; Pei-Fang Lai; Wei-Hua Li; Heng Lin
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

8.  MicroRNA-15a Inhibits Proliferation and Induces Apoptosis in CNE1 Nasopharyngeal Carcinoma Cells.

Authors:  Kang Zhu; Ying He; Cui Xia; Jing Yan; Jin Hou; Demin Kong; Yeye Yang; Guoxi Zheng
Journal:  Oncol Res       Date:  2016       Impact factor: 5.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.